Gujarat State Fertilizers & Chemicals Ltd
Incorporated in 1962, Gujarat State Fertilizers & Chemicals Ltd is a public sector company promoted by the Government of Gujarat. It is engaged in manufacturing of various fertilizers and industrial products like plastics & synthetic rubbers and man-made fibres [1]
- Market Cap ₹ 7,699 Cr.
- Current Price ₹ 193
- High / Low ₹ 322 / 183
- Stock P/E 14.6
- Book Value ₹ 334
- Dividend Yield 2.07 %
- ROCE 5.50 %
- ROE 4.27 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Stock is trading at 0.58 times its book value
- Company has been maintaining a healthy dividend payout of 24.1%
Cons
- The company has delivered a poor sales growth of 0.82% over past five years.
- Company has a low return on equity of 7.84% over last 3 years.
- Earnings include an other income of Rs.334 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Fertilizers Industry: Fertilizers
Part of BSE 500 BSE 400 MidSmallCap Index Nifty 500 BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6,236 | 5,386 | 5,311 | 6,108 | 5,265 | 6,271 | 8,575 | 7,621 | 7,500 | 8,998 | 11,298 | 8,932 | 8,650 | |
5,437 | 4,820 | 4,720 | 5,453 | 4,778 | 5,704 | 7,827 | 7,314 | 6,950 | 7,685 | 9,680 | 8,449 | 8,114 | |
Operating Profit | 799 | 566 | 591 | 656 | 487 | 567 | 748 | 307 | 549 | 1,312 | 1,618 | 483 | 536 |
OPM % | 13% | 10% | 11% | 11% | 9% | 9% | 9% | 4% | 7% | 15% | 14% | 5% | 6% |
137 | 120 | 102 | 65 | 57 | 94 | 105 | 105 | 183 | 180 | 146 | 376 | 334 | |
Interest | 36 | 45 | 18 | 31 | 65 | 51 | 61 | 115 | 43 | 10 | 15 | 11 | 12 |
Depreciation | 132 | 145 | 101 | 97 | 103 | 119 | 126 | 170 | 176 | 178 | 182 | 183 | 187 |
Profit before tax | 768 | 495 | 574 | 593 | 375 | 491 | 665 | 127 | 513 | 1,305 | 1,568 | 664 | 671 |
Tax % | 33% | 31% | 30% | 31% | -12% | 3% | 26% | 22% | 19% | 32% | 18% | 21% | |
518 | 342 | 401 | 409 | 420 | 476 | 494 | 99 | 418 | 891 | 1,293 | 524 | 529 | |
EPS in Rs | 13.00 | 8.59 | 10.05 | 10.27 | 10.53 | 11.94 | 12.39 | 2.48 | 10.48 | 22.36 | 32.45 | 13.16 | 13.26 |
Dividend Payout % | 15% | 23% | 22% | 21% | 21% | 18% | 18% | 48% | 21% | 11% | 31% | 30% |
Compounded Sales Growth | |
---|---|
10 Years: | 5% |
5 Years: | 1% |
3 Years: | 6% |
TTM: | -21% |
Compounded Profit Growth | |
---|---|
10 Years: | 4% |
5 Years: | 1% |
3 Years: | 11% |
TTM: | -49% |
Stock Price CAGR | |
---|---|
10 Years: | 6% |
5 Years: | 22% |
3 Years: | 19% |
1 Year: | 6% |
Return on Equity | |
---|---|
10 Years: | 7% |
5 Years: | 6% |
3 Years: | 8% |
Last Year: | 4% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 |
Reserves | 3,862 | 4,111 | 4,385 | 5,426 | 6,495 | 7,182 | 7,188 | 6,718 | 9,064 | 11,589 | 11,884 | 12,531 | 13,234 |
1,505 | 789 | 744 | 1,288 | 805 | 1,093 | 1,069 | 1,559 | 37 | 6 | 2 | 5 | 101 | |
1,471 | 1,566 | 1,244 | 1,543 | 1,648 | 1,885 | 2,015 | 1,667 | 1,838 | 2,301 | 1,807 | 2,264 | 2,326 | |
Total Liabilities | 6,918 | 6,545 | 6,452 | 8,337 | 9,028 | 10,240 | 10,351 | 10,024 | 11,019 | 13,975 | 13,773 | 14,880 | 15,740 |
1,365 | 2,016 | 1,958 | 1,653 | 2,019 | 2,105 | 2,813 | 2,895 | 2,798 | 2,674 | 2,574 | 2,544 | 2,498 | |
CWIP | 684 | 185 | 260 | 403 | 272 | 761 | 187 | 107 | 117 | 157 | 199 | 235 | 463 |
Investments | 672 | 827 | 858 | 1,694 | 2,479 | 2,740 | 2,315 | 2,023 | 4,284 | 6,265 | 5,279 | 5,956 | 6,634 |
4,196 | 3,517 | 3,377 | 4,587 | 4,259 | 4,633 | 5,036 | 4,999 | 3,820 | 4,878 | 5,721 | 6,145 | 6,144 | |
Total Assets | 6,918 | 6,545 | 6,452 | 8,337 | 9,028 | 10,240 | 10,351 | 10,024 | 11,019 | 13,975 | 13,773 | 14,880 | 15,740 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-887 | 1,573 | 258 | -242 | 907 | 361 | 507 | -24 | 1,769 | 252 | 929 | -272 | |
-637 | -412 | -134 | -170 | -238 | -488 | -279 | -266 | -24 | -19 | -40 | 105 | |
786 | -938 | -155 | 410 | -656 | 133 | -242 | 267 | -1,560 | -125 | -114 | -403 | |
Net Cash Flow | -737 | 223 | -31 | -2 | 13 | 7 | -13 | -23 | 185 | 108 | 775 | -570 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 170 | 134 | 133 | 197 | 55 | 56 | 40 | 43 | 23 | 15 | 16 | 21 |
Inventory Days | 62 | 77 | 70 | 56 | 82 | 74 | 90 | 90 | 69 | 90 | 62 | 78 |
Days Payable | 48 | 65 | 39 | 54 | 70 | 75 | 63 | 29 | 37 | 53 | 31 | 48 |
Cash Conversion Cycle | 184 | 147 | 164 | 199 | 67 | 55 | 68 | 104 | 55 | 51 | 47 | 50 |
Working Capital Days | 161 | 115 | 131 | 174 | 178 | 154 | 125 | 167 | 110 | 116 | 92 | 84 |
ROCE % | 17% | 10% | 12% | 10% | 6% | 7% | 9% | 3% | 6% | 13% | 13% | 6% |
Documents
Announcements
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
1d - Information on requests for lost share certificates.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
20 Nov - Transcript of Q2 FY25 earnings conference call.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
13 Nov - Audio recording of investor conference call on financial results.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 Nov - Newspaper publication of Unaudited financial results for the Quarter ended 30th September, 2024.
-
In-Principle Approval For Investment In Vadodara Jal Sanchay Pvt Ltd ("VJSPL"), Subsidiary Of The Company
12 Nov - Approval for Rs. 28.85 crores investment in VJSPL.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
-
Financial Year 2011
from bse
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Feb 2024TranscriptNotesPPT REC
-
Nov 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT REC
-
May 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022TranscriptPPT
-
Jul 2022TranscriptPPT
-
May 2021TranscriptPPT
-
Dec 2017TranscriptPPT
Market Leader in Carpolactam
GSFC is a market leader in the value chain of Carpolactam, Nylon 6 virgin polymer and its compounds. The compounds of Nylon 6 are used in diverse performance applications ranging from consumer durables and automotives.[1]